Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Viemed Healthcare, Inc. (VMD : NSDQ)

• Company Description    Viemed Healthcare Inc. is a home medical equipment supplier which provides post-acute respiratory care services through its subsidiaries Sleep Management L.L.C. and Home Sleep Delivered L.L.C. Viemed Healthcare Inc. is based in Lafayette, United States. Number of Employees: 627

• Price / Volume Information    Yesterday's Closing Price: $5.68 Daily Weekly Monthly 20 Day Moving Average: 141,342 shares Shares Outstanding: 39.64 (millions) Market Capitalization: $225.16 (millions) Beta: 1.45 52 Week High: $9.12 52 Week Low: $3.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.46% 12.91% 12 Week 47.15% 54.92% Year To Date 8.81% 26.84%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 625 East Kaliste Saloom Road - Lafayette,LA 70508 USA ph: 337-504-3802 fax: - glen@bristolir.com http://www.viemed.com

• General Corporate Information    Officers Casey Hoyt - Chief Executive Officer Randy Dobbs - Chairman Trae Fitzgerald - Chief Financial Officer Bruce Greenstein - Director Sabrina Heltz - Director Peer Information Viemed Healthcare, Inc. (BJCT) Viemed Healthcare, Inc. (CADMQ) Viemed Healthcare, Inc. (APNO) Viemed Healthcare, Inc. (UPDC) Viemed Healthcare, Inc. (IMTIQ) Viemed Healthcare, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92663R105 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/01/22 Share - Related Items Shares Outstanding: 39.64 Most Recent Split Date: (:1) Beta: 1.45 Market Capitalization: $225.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.13 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/01/22

• Fundamental Ratios P/E Current FY Estimate: 43.69 Trailing 12 Months: 25.82 PEG Ratio: - Price Ratios Price/Book: 2.34 Price/Cash Flow: 11.02 Price / Sales: 1.86 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: -60.00% Sales Growth vs. Year Ago Period: 13.51% vs. Previous Quarter: 0.92% ROE 03/31/22 - 10.05 12/31/21 - 10.31 09/30/21 - 11.87 ROA 03/31/22 - 7.94 12/31/21 - 7.98 09/30/21 - 8.95 Current Ratio 03/31/22 - 2.70 12/31/21 - 2.66 09/30/21 - 2.35 Quick Ratio 03/31/22 - 2.55 12/31/21 - 2.52 09/30/21 - 2.22 Operating Margin 03/31/22 - 7.61 12/31/21 - 7.80 09/30/21 - 8.69 Net Margin 03/31/22 - 7.61 12/31/21 - 7.80 09/30/21 - 8.69 Pre-Tax Margin 03/31/22 - 11.21 12/31/21 - 10.68 09/30/21 - 10.89 Book Value 03/31/22 - 2.42 12/31/21 - 2.39 09/30/21 - 2.26 Inventory Turnover 03/31/22 - 17.94 12/31/21 - 17.71 09/30/21 - 17.87 Debt-to-Equity 03/31/22 - 0.05 12/31/21 - 0.05 09/30/21 - 0.06 Debt-to-Capital 03/31/22 - 4.47 12/31/21 - 4.60 09/30/21 - 5.48

Powered by Zacks Investment Research ©